LYRA THERAPEUTICS
Lyra Therapeutics, Inc. is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat diseases. The company’s proprietary technology platform, XTreo, is designed to precisely and consistently deliver medicines directly to the affected tissue for sustained periods with a single administration. The company’s initial product candidates, LYR-210 and LYR-... 220, are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver up to six months of continuous drug therapy to the sinonasal passages for the treatment of CRS. The therapeutic embedded within LYR-210 and LYR-220 is mometasone furoate, which is the active ingredient in various FDA-approved drugs and has a well-established efficacy and safety profile.
LYRA THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics Wellness
Founded:
2005-01-01
Address:
Watertown, Massachusetts, United States
Country:
United States
Website Url:
http://www.lyratherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
617.393.4600
Total Funding:
214.09 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Font Awesome
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Amicus Therapeutics
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Dystrogen Therapeutics
Dystrogen Therapeutics is a clinical-stage regenerative medicine company focusing on rare diseases.
Eliem Therapeutics
Eliem Therapeutics is a clinical-stage biotechnology company developing treatments for nervous system disorders.
Keeps
Keeps is a startup aimed at preventing and slowing age-related hair loss.
Koya Medical
Koya Medical is a transformative healthcare company developing breakthrough treatments for lymphedema and venous diseases.
LifeGuides, PBC
Modernizing human support & learning - The Marketplace for Life Experience. More casual than therapy, more qualified than a friend. B2B SaaS
Lyndra Therapeutics
Lyndra Therapeutics is a novel technology platform reinventing medicine for a healthier world.
MBX Biosciences
MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.
Medable
Medable is transforming clinical research and predictive medicine by creating a platform powered by patient generated data.
NorthSea Therapeutics
NorthSea Therapeutics is a clinical-stage biotech company developing first-in class, oral, structurally-engineered lipid therapeutics.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
OneSkin
OneSkin is a longevity company developing products designed to extend skin and body health by targeting aging at its source.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
Primaeva Medical
Primaeva Medical is a venture capital funded company developing devices for dermatologists, plastic surgeons and other cosmetic physicians.
Pure Scientific Technologies
Pure Scientific Technologies is a medical device startup company that develops a new patent-pending drug delivery system.
Thermaband
Thermaband is a health and wellness company empowering menopausal women with personal comfort on demand through a cooling/warming wearable.
Treadwell Therapeutics
Treadwell Therapeutics is a clinical-stage oncology company that develops medicines to address unmet needs in patients with cancer.
X4 Pharmaceuticals
X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment.
Current Advisors List
Board_member
Current Employees Featured
George Whitesides Co-Founder @ Lyra Therapeutics
Co-Founder
Robert Langer Co-founder @ Lyra Therapeutics
Co-founder
Maria Palasis President, CEO @ Lyra Therapeutics
President, CEO
2018-01-01
Corinne Noyes Senior Vice President of Commercial Strategy & Market Development @ Lyra Therapeutics
Senior Vice President of Commercial Strategy & Market Development
Harlan W. Waksal Executive Chairman @ Lyra Therapeutics
Executive Chairman
2022-02-01
Richard Nieman Chief Medical Officer @ Lyra Therapeutics
Chief Medical Officer
2022-07-01
Pamela Nelson Senior Vice President, Regulatory Affairs @ Lyra Therapeutics
Senior Vice President, Regulatory Affairs
2020-08-01
Vineeta Belanger Senior Vice President, Clinical Affairs @ Lyra Therapeutics
Senior Vice President, Clinical Affairs
2019-09-01
Jason Cavalier Chief Financial Officer @ Lyra Therapeutics
Chief Financial Officer
2021-01-01
R Don Elsey Chief Financial Officer @ Lyra Therapeutics
Chief Financial Officer
2019-08-01
Founder
Stock Details
Investors List
Perceptive Advisors
Perceptive Advisors investment in Post-IPO Equity - Lyra Therapeutics
Samsara BioCapital
Samsara BioCapital investment in Post-IPO Equity - Lyra Therapeutics
North Bridge Venture Partners & Growth Equity
North Bridge Venture Partners & Growth Equity investment in Post-IPO Equity - Lyra Therapeutics
Nantahala Capital Management
Nantahala Capital Management investment in Post-IPO Equity - Lyra Therapeutics
Pura Vida Investments
Pura Vida Investments investment in Post-IPO Equity - Lyra Therapeutics
Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners investment in Post-IPO Equity - Lyra Therapeutics
RA Capital Management
RA Capital Management investment in Series C - Lyra Therapeutics
Soleus Capital
Soleus Capital investment in Series C - Lyra Therapeutics
Perceptive Advisors
Perceptive Advisors investment in Series C - Lyra Therapeutics
Polaris Partners
Polaris Partners investment in Series C - Lyra Therapeutics
Key Employee Changes
Official Site Inspections
http://www.lyratherapeutics.com Semrush global rank: 4.67 M Semrush visits lastest month: 2.09 K
- Host name: 169.101.198.104.bc.googleusercontent.com
- IP address: 104.198.101.169
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Lyra Therapeutics"
Company - Lyra Therapeutics
Lyra Therapeutics is a clinical-stage biotechnology company developing innovative therapies for the localized treatment of chronic rhinosinusitis (CRS), an inflammatory disease of the paranasal sinuses which leads to debilitating …See details»
Lyra Therapeutics - Lyra Therapeutics
Lyra Therapeutics is at the point of impact for CRS. Lyra Therapeutics is a clinical-stage biotechnology company developing innovative therapies for the localized treatment of chronic …See details»
Leadership - Lyra Therapeutics
Woodford L. and Ann A. Flowers University Professor, Harvard University ... ...See details»
Lyra Therapeutics - Crunchbase Company Profile
Lyra Therapeutics, Inc. is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery …See details»
Lyra Therapeutics, Inc. (LYRA)
See the company profile for Lyra Therapeutics, Inc. (LYRA) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Lyra Therapeutics (LYRA) Company Profile & Description - Stock …
May 1, 2020 Lyra Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of anti-inflammatory therapies for the treatment of …See details»
Lyra Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Lyra Therapeutics, Inc. of Watertown, MA. Get the latest business insights from Dun & Bradstreet.See details»
Lyra Therapeutics - The Org
Creating precisely tuned medicines so patients can breathe freely, Lyra Therapeutics is pioneering a new therapeutic approach to treat debilitating ear, nose and throat diseases that …See details»
Lyra Therapeutics Company Profile | Management and Employees …
Www.lyratherapeutics.com Lyra Therapeutics Profile and History Lyra Therapeutics, Inc. is a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform to enable …See details»
Corporate Governance - Lyra Therapeutics, Inc.
The Board of Directors of Lyra Therapeutics, Inc. (the "Company") sets high standards for the Company's employees, officers and directors. Implicit in this philosophy is the importance of …See details»
Lyra Therapeutics - Craft
Oct 29, 2024 Lyra Therapeutics has 1 employees at their 1 location and $1.53 m in annual revenue in FY 2024. See insights on Lyra Therapeutics including office locations, competitors, …See details»
Lyra Therapeutics - LinkedIn
Lyra Therapeutics | 8,322 followers on LinkedIn. Clinical-stage biotechnology company developing innovative therapies for the localized treatment of CRS | Lyra Therapeutics is a …See details»
Lyra Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Www.lyratherapeutics.com. Public Company | 2005 | Massachusetts, United States | 50-100 | NASDAQ: LYRA | www.lyratherapeutics.com. Last update 08 Mar 2025. Overview. Pipeline. ...See details»
Lyra Therapeutics
Mar 13, 2025 Lyra Therapeutics was founded in 2017 with the mission to discover and develop breakthrough therapies for ENT diseases by leveraging innovation in drug delivery combined …See details»
Lyra Therapeutics - MassBio
Lyra Therapeutics, Inc. is a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform to enable precise, sustained, local delivery of medications to diseased tissues not …See details»
Working At Lyra Therapeutics: Company Overview and Culture
Lyratherapeutics.com. Organization Type. Public. Lyra Therapeutics, Inc. is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated …See details»
Lyra Therapeutics CEO and Key Executive Team | Craft.co
Lyra Therapeutics's President and Chief Executive Officer, Director is Maria Palasis. Other executives include Corinne Noyes, Senior Vice President of Commercial Strategy & Market …See details»
News Releases - Lyra Therapeutics, Inc.
Mar 13, 2025 Company continues to focus on upcoming results from ENLIGHTEN 2 pivotal Phase 3 trial in CRS patients, expected in 2Q 2025 In parallel, the Company continues to …See details»
Lyra Health Unveils AI Platform to Build Workforce Resilience
Apr 22, 2025 Lyra Empower Integrates AI-Powered Solutions for Highest ROI in Mental Health. April 22, 2025 – BURLINGAME, Calif. – Lyra Health, the leading provider of Workforce Mental …See details»
Lyra Therapeutics-Lyra Therapeutics, Inc.-企业详情-InvestGO数据 …
查看医药魔方InvestGO®数据库Lyra Therapeutics的公司信息。Lyra Therapeutics（Lyra Therapeutics, Inc.），公司简介：Lyra Therapeutics, Inc. is a clinical-stage therapeutics …See details»